United States: COVID-19 infection has been linked gut, brain and lung problems that may develop after almost three (3) years after the viral infection has passed, according to a latest study.
The conclusion has been made after analysing and studying around millions of Veteran Affairs records from the first year of the COVID-19 pandemic. The study was conducted before the vaccines and antivirals were rollout, according to KERA News.
As many as 114,000 and 5 million veterans were compared by the researchers who were suffering from mild COVID-19 and didn’t have COVID, respectively.
According to the reports, people with mild COVID-19 infection were:
22 percent more likely to have pulmonary issues,
10 percent more likely to have neurological problems, and
8 percent more likely to have Gastrointestinal issue.
The matter was explained by a neurointesivist with Texas Health Fort Worth – Dr Ishwara Sankara, who told KERA News that COVID-19 has revealed that the inflammatory process following a viral infection can last much longer than previously thought.
Historical data, especially from studies on the Epstein-Barr virus, showed that long-term consequences can occur after infection. Similarly, COVID-19 appears to trigger a prolonged inflammatory response in the body. Recent studies indicate that this inflammation can persist for up to three years, as per KERA.
Is it conceivable that the inflammation instigated by COVID-19 could remain dormant, manifesting complications much later?
A particular study delved into this, revealing that even two to three years post-infection, patients may still face severe repercussions, notably those prone to cerebrovascular events. This heightened risk persists notably among individuals who were hospitalized due to COVID-19.
Connection or Causation?
Determining a direct causation remains elusive. The data suggest that individuals with pre-existing conditions such as obesity and diabetes, especially those who require acute hospitalization, face elevated mortality rates. It appears that COVID-19 exacerbates these vulnerabilities, prolonging the risk of symptom recurrence well beyond the initial infection period.
Differentiating from Long COVID
Unlike long COVID, where symptoms persist immediately post-recovery, this phenomenon involves a latent period before complications resurface. Symptoms of long COVID include persistent fatigue, cognitive impairment, and sensory loss, extending from weeks to several years post-infection, according to KERA.
This study highlights that the risk of developing neurological, gastrointestinal, or cardiovascular complications remains elevated for up to three years post-COVID-19. Fortunately, the incidence rate seems to decline after this period.
Treatment Implications
The query of whether these lingering conditions are harder to treat remains unanswered. Clinicians now consider a history of COVID-19 infection when evaluating patients with new strokes or transient ischemic attacks. Although treatment protocols remain consistent, the recognition of increased stroke risk in post-COVID patients, especially younger individuals and those previously hospitalized, is crucial.
This knowledge prompts a change in medical practice: routinely inquiring about past COVID-19 hospitalization when assessing new stroke cases.
The Essential Takeaway
While this information might alarm the early COVID-19 patients, it underscored the importance of proactive health management. Key preventive measures including regular exercise, a balanced diet, abstinence from smoking, and consistent medical check-ups.